ES2057164T3 - Fragmentos de acido nucleico especificos del gen de la vilina humana y su utilizacion con fines diagnosticos. - Google Patents

Fragmentos de acido nucleico especificos del gen de la vilina humana y su utilizacion con fines diagnosticos.

Info

Publication number
ES2057164T3
ES2057164T3 ES89402984T ES89402984T ES2057164T3 ES 2057164 T3 ES2057164 T3 ES 2057164T3 ES 89402984 T ES89402984 T ES 89402984T ES 89402984 T ES89402984 T ES 89402984T ES 2057164 T3 ES2057164 T3 ES 2057164T3
Authority
ES
Spain
Prior art keywords
nucleic acid
human
gene
viline
acid fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89402984T
Other languages
English (en)
Inventor
Monique Arpin
Eric Pringault
Alphonse Garcia
Daniel Louvard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Application granted granted Critical
Publication of ES2057164T3 publication Critical patent/ES2057164T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4735—Villin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA INVENCION SE REFIERE A FRAGMENTOS DE ACIDO NUCLEICO, CARACTERIZADOS PORQUE CONTIENEN DE 8-40 NUCLEOTIDOS Y PORQUE SU SECUENCIA ESTA CONTENIDA YA EN LA SECUENCIA DE ADN QUE CODIFICA PARA EL GENE DE LA VILLINA HUMANA YA EN TODO FRAGMENTO DE ADN EXACTAMENTE COMPLEMENTARIO DE UNO DE LOS PRECEDENTES Y QUE CONTIENE DE ESTA FORMA EL MISMO NUMERO DE DESOXINUCLEOTIDOS, YA EN TODO FRAGMENTO DE ARN CORRESPONDIENTE Y QUE CONTIENE EL MISMO NUMERO DE RIBONUCLEOTIDOS. LA INVENCION CONTEMPLA TAMBIEN LA APLICACION DE ESTOS FRAGMENTOS EN UN PROCEDIMIENTO PARA DETECTAR IN VITRO LA PRESENCIA DE UN ACIDO NUCLEICO CARACTERISTICO DE LA VILLINA HUMANA.
ES89402984T 1988-10-28 1989-10-27 Fragmentos de acido nucleico especificos del gen de la vilina humana y su utilizacion con fines diagnosticos. Expired - Lifetime ES2057164T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8814208A FR2638464B1 (fr) 1988-10-28 1988-10-28 Fragments d'acide nucleique specifiques du gene de la villine humaine, leur utilisation aux fins de diagnostic

Publications (1)

Publication Number Publication Date
ES2057164T3 true ES2057164T3 (es) 1994-10-16

Family

ID=9371435

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89402984T Expired - Lifetime ES2057164T3 (es) 1988-10-28 1989-10-27 Fragmentos de acido nucleico especificos del gen de la vilina humana y su utilizacion con fines diagnosticos.

Country Status (8)

Country Link
US (1) US5652101A (es)
EP (1) EP0367666B1 (es)
JP (1) JPH02283285A (es)
AT (1) ATE108834T1 (es)
DE (1) DE68916905T2 (es)
ES (1) ES2057164T3 (es)
FR (1) FR2638464B1 (es)
HK (1) HK74595A (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830729A (en) 1996-04-18 1998-11-03 Institut Pasteur I Sce I-induced gene replacement and gene conversion in embryonic stem cells
EP2329261B1 (en) * 2008-09-12 2014-06-18 Dako Denmark A/S Prostate cancer biomarker

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS1355B6 (is) * 1984-11-12 1989-04-19 Lister Institute Of Preventive Medicine Fjölkjarna kannar
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
WO1986006494A2 (fr) * 1985-05-02 1986-11-06 Pasteur Institut Moyens pour le diagnostic in vitro de cellules malignesorigi naires du tube digestif
US5188967A (en) * 1985-05-02 1993-02-23 Institut Pasteur Agents for the in vitro diagnosis of malignant cells originating in the digestive tract

Also Published As

Publication number Publication date
HK74595A (en) 1995-05-19
JPH02283285A (ja) 1990-11-20
DE68916905T2 (de) 1995-01-05
DE68916905D1 (de) 1994-08-25
FR2638464A1 (fr) 1990-05-04
FR2638464B1 (fr) 1992-01-03
EP0367666B1 (fr) 1994-07-20
ATE108834T1 (de) 1994-08-15
EP0367666A1 (fr) 1990-05-09
US5652101A (en) 1997-07-29

Similar Documents

Publication Publication Date Title
ES2159635T3 (es) Secuenciado de adn por ligazon y escindido por etapas.
ES2053648T3 (es) Proceso de ampliacion de un acido nucleico.
PT969102E (pt) Iniciadores, grupos e conjuntos de fragmentos de restrição usados na amplificação selectiva de fragmentos de restrição
LTIP1531A (en) Method for the determination of dna molecule nucleotides bases sequence
DE3280400D1 (de) Oligonukleotides heilmittel und dessen herstellungsverfahren.
IL76143A (en) Composition and method for the detection of the presence of complementary polynucleotide sequences and hybridization
DE69220946D1 (de) Verwendung von nukleinsäureanaloga in diagnostischen und analytischen verfahren
NO895090L (no) Fremgangsmaate og system for deteksjonsdiagnostisering.
DE69133629D1 (de) nssystem zur Bestimmung von genetischen Krankheiten
FI902318A0 (fi) Foerfarande foer framstaellning av ribonukleinsyra (rna).
DE69636080D1 (de) Eine in Kaskaden verlaufende Vervielfältigungsreaktion von Nukleinsäuren
DE3583564D1 (de) Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
DK120091A (da) Tripelstrenget nukleinsyre og anvendelse heraf
MY102570A (en) Polynucleotide probes
DK374686D0 (da) Knoglemorphogenetiske midler, fremgangsmaade til fremstilling deraf og dna-sekvenser, nucleinsyresonder og rekombinante udtrykkelsesmedier til anvendelse derved
EP0641215A4 (en) PROTEASE-RESISTANT ANALOGS OF THROMBOMODULIN.
Padmanabhan et al. Chemical synthesis of a primer and its use in the sequence analysis of the lysozyme gene of bacteriophage T4
EP0274482A4 (en) Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells.
Endow Analysis of Drosophila melanogaster satellite IV with restriction endonuclease MboII
ES2057164T3 (es) Fragmentos de acido nucleico especificos del gen de la vilina humana y su utilizacion con fines diagnosticos.
DE3786181D1 (de) Dns-probe, spezifisch fuer das maennliche genom der wiederkaeuer, ihre herstellung und verwendung.
DE3884669D1 (de) Verfahren zur Herstellung von doppelsträngiger DNA.
Roychoudhury et al. Influence of nucleotide sequence adjacent to duplex DNA termini on 3′ terminal labeling by terminal transferase
WO1999037764A3 (en) New members of the glypican gene family
GR3021418T3 (en) Identification of novel drugs and reagents.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 367666

Country of ref document: ES